Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort.

Date publication

avril 2020

Journal

Breast (Edinburgh, Scotland)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr COUDERT Bruno , Dr EYMARD Jean-Christophe , Pr PETIT Thierry

Tous les auteurs :
Frank S, Carton M, Dubot C, Campone M, Pistilli B, Dalenc F, Mailliez A, Levy C, D'Hondt V, Debled M, Vermeulin T, Coudert B, Perrin C, Gonçalves A, Uwer L, Ferrero JM, Eymard JC, Petit T, Mouret-Reynier MA, Patsouris A, Guesmia T, Bachelot T, Robain M, Cottu P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32380440

Résumé

Young age is a poor prognostic factor in early stage breast cancer (BC) but its value is less established in metastatic BC (MBC). We evaluated the impact of age at MBC diagnosis on overall survival (OS) across three age groups (<40, 40 to 60 and > 60 years(y)).

Mots clés

Age, Breast cancer, Metastatic disease, Overall survival, Real-world data

Référence

Breast. 2020 Apr 23;52:50-57